PEGylated poly (amidoamine) dendrimers-based drug loading vehicles for delivering carboplatin in treatment of various cancerous cells
The fourth generation (G4) of poly (amidoamine) dendrimer was PEGylated and then
physically incorporated with carboplatin to develop the new drug delivery carrier. The proton …
physically incorporated with carboplatin to develop the new drug delivery carrier. The proton …
Octa-arginine modified poly (amidoamine) dendrimers for improved delivery and cytotoxic effect of paclitaxel in cancer
Cell penetrating peptides (CPP) have the ability to penetrate the cell membrane and have
been associated with various cargos for their facile intracellular translocation. The current …
been associated with various cargos for their facile intracellular translocation. The current …
Preparation and characterization of oxaliplatin drug delivery vehicle based on PEGylated half-generation PAMAM dendrimer
DTD Nguyen, LG Bach, TH Nguyen, MH Ho… - Journal of Polymer …, 2019 - Springer
Dendrimers were well-known as a polymeric nanoparticle drug carrier system. Among them,
polyamidoamine (PAMAM) dendrimers were firstly and systematically studied. Herein, to …
polyamidoamine (PAMAM) dendrimers were firstly and systematically studied. Herein, to …
Dendrimer-based nanocarriers demonstrating a high efficiency for loading and releasing anticancer drugs against cancer cells in vitro and in vivo
Dendrimer, a new class of hyper-branched polymer with predetermined molecular weight
and well-controlled size, has received much attention in nanobiomedical applications such …
and well-controlled size, has received much attention in nanobiomedical applications such …
[HTML][HTML] Modified carboxyl-terminated PAMAM dendrimers as great cytocompatible nano-based drug delivery system
MT Vu, LG Bach, DC Nguyen, MN Ho… - International Journal of …, 2019 - mdpi.com
Polyamidoamine (PAMAM) dendrimers are extensively researched as potential drug
delivery system thanks to their desirable features such as controlled and stable structures …
delivery system thanks to their desirable features such as controlled and stable structures …
Effective elimination of charge-associated toxicity of low generation polyamidoamine dendrimer eases drug delivery of oxaliplatin
VMH Do, LG Bach, DHN Tran, VD Cao… - Biotechnology and …, 2020 - Springer
Polyamidoamine (PAMAM) dendrimer is emerging as an effective nanocarrier for delivering
anticancer drugs. Still, unmodified PAMAM dendrimer is hardly used in vivo because of …
anticancer drugs. Still, unmodified PAMAM dendrimer is hardly used in vivo because of …
[HTML][HTML] Partial surface modification of low generation polyamidoamine dendrimers: Gaining insight into their potential for improved carboplatin delivery
DH Nguyen, LG Bach, DH Nguyen Tran, VD Cao… - Biomolecules, 2019 - mdpi.com
Carboplatin (CAR) is a second generation platinum-based compound emerging as one of
the most widely used anticancer drugs to treat a variety of tumors. In an attempt to address …
the most widely used anticancer drugs to treat a variety of tumors. In an attempt to address …
Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy
Because of the synergistic effects of drugs and minimal drug dose for cancer therapy,
combination chemotherapy is frequently used in the clinic. In this study, hyaluronic acid …
combination chemotherapy is frequently used in the clinic. In this study, hyaluronic acid …
Tumor targeting using polyamidoamine dendrimer–cisplatin nanoparticles functionalized with diglycolamic acid and herceptin
A Kesavan, P Ilaiyaraja, WS Beaula, VV Kumari… - European Journal of …, 2015 - Elsevier
Polymer mediated drug delivery system represents a novel promising platform for tumor-
targeting with reduced systemic side effects and improved chemotherapeutical efficacy. In …
targeting with reduced systemic side effects and improved chemotherapeutical efficacy. In …
Glutaryl polyamidoamine dendrimer for overcoming cisplatin-resistance of breast cancer cells
X Xu, Y Li, X Lu, Y Sun, J Luo… - Journal of Nanoscience …, 2018 - ingentaconnect.com
Objective: Cisplatin has limited clinical applications due to drug resistance. PAMAM
dendrimer was chosen as a vehicle to counteract cisplatin-resistance and its mechanism …
dendrimer was chosen as a vehicle to counteract cisplatin-resistance and its mechanism …